| Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation C Lerman, R Tyndale, F Patterson, EP Wileyto, PG Shields, A Pinto, ... Clinical Pharmacology & Therapeutics 79 (6), 600-608, 2006 | 335 | 2006 |
| Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo … C Lerman, RA Schnoll, LW Hawk, P Cinciripini, TP George, EP Wileyto, ... The lancet Respiratory medicine 3 (2), 131-138, 2015 | 281 | 2015 |
| Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study RA Schnoll, F Patterson, EP Wileyto, RF Tyndale, N Benowitz, C Lerman Pharmacology Biochemistry and Behavior 92 (1), 6-11, 2009 | 239 | 2009 |
| The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial C Lerman, EP Wileyto, F Patterson, M Rukstalis, J Audrain-McGovern, ... The pharmacogenomics journal 4 (3), 184-192, 2004 | 236 | 2004 |
| Toward personalized therapy for smoking cessation: a randomized placebo‐controlled trial of bupropion F Patterson, RA Schnoll, EP Wileyto, A Pinto, LH Epstein, PG Shields, ... Clinical Pharmacology & Therapeutics 84 (3), 320-325, 2008 | 200 | 2008 |
| Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM) ME Piper, DE McCarthy, DM Bolt, SS Smith, C Lerman, N Benowitz, ... Nicotine & Tobacco Research 10 (6), 1009-1020, 2008 | 173 | 2008 |
| Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS) Evidence of … BL Lee, M Ileana, NL Benowitz, J Peyton III, CB Wofsy, MV John Annals of internal medicine 110 (8), 606-611, 1989 | 165 | 1989 |
| Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial C Lerman, V Kaufmann, M Rukstalis, F Patterson, K Perkins, ... Annals of internal medicine 140 (6), 426-433, 2004 | 149 | 2004 |
| Individual differences in nicotine intake per cigarette F Patterson, N Benowitz, P Shields, V Kaufmann, C Jepson, P Wileyto, ... Cancer Epidemiology Biomarkers & Prevention 12 (5), 468-471, 2003 | 119 | 2003 |
| Genetic variation in nicotine metabolism predicts the efficacy of extended‐duration transdermal nicotine therapy C Lerman, C Jepson, EP Wileyto, F Patterson, R Schnoll, M Mroziewicz, ... Clinical Pharmacology & Therapeutics 87 (5), 553-557, 2010 | 117 | 2010 |
| Quantitative determination of Δ9-THC, CBG, CBD, their acid precursors and five other neutral cannabinoids by UHPLC-UV-MS YH Wang, B Avula, MA ElSohly, MM Radwan, M Wang, AS Wanas, ... Planta Medica 84 (04), 260-266, 2018 | 56 | 2018 |
| CYP2B6 Genotype Does Not Alter Nicotine Metabolism, Plasma Levels, or Abstinence with Nicotine Replacement Therapy AM Lee, C Jepson, PG Shields, N Benowitz, C Lerman, RF Tyndale Cancer Epidemiology Biomarkers & Prevention 16 (6), 1312-1314, 2007 | 56 | 2007 |
| 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: operator and institutional recommendations and requirements for transcatheter mitral valve intervention: a … RO Bonow, PT O’Gara, DH Adams, V Badhwar, JE Bavaria, S Elmariah, ... Journal of the American College of Cardiology 76 (1), 96-117, 2020 | 45 | 2020 |
| Association of the Nicotine Metabolite Ratio and CHRNA5/CHRNA3 Polymorphisms With Smoking Rate Among Treatment-Seeking Smokers M Falcone, C Jepson, N Benowitz, AW Bergen, A Pinto, EP Wileyto, ... Nicotine & Tobacco Research 13 (6), 498-503, 2011 | 37 | 2011 |
| A systems biology network model for genetic association studies of nicotine addiction and treatment PD Thomas, H Mi, GE Swan, C Lerman, N Benowitz, RF Tyndale, ... Pharmacogenetics and genomics 19 (7), 538-551, 2009 | 21 | 2009 |
| Once-daily dosing of aminoglycosides: how much monitoring is truly required? L Winston, N Benowitz The American journal of medicine 114 (3), 239-240, 2003 | 18 | 2003 |
| A randomized placebo-controlled trial to test a genetically-informed biomarker ForPersonalizing treatment for tobacco dependence C Lerman, RA Schnoll, LW Hawk Jr, P Cinciripini, TP George, EP Wileyto, ... The Lancet. Respiratory medicine 3 (2), 131, 2015 | 17 | 2015 |
| Coffee, alcohol, and the liver DS Sharp, JE Everhart, NL Benowitz Annals of epidemiology 9 (7), 391-393, 1999 | 17 | 1999 |
| SRNT subcommittee on biochemical verification NL Benowitz, P Jacob, K Ahijevych, M Jarvis, S Hall, J LeHouezec Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4 (2 …, 2002 | 13 | 2002 |
| The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opioids DI Abrams, C Jay, K Petersen, S Shade, H Vizoso, H Reda, N Benowitz, ... Program and abstracts of the 2nd conference on Cannabinoids in Medicine [en …, 2003 | 12 | 2003 |
